Bonafide Health acquired by Pharmavite
Pharmavite acquired Bonafide Health, a women's health supplements brand.
Transaction summary
- Target
- Bonafide Health
- Acquirer
- Pharmavite
- Seller
- -
- Announced
- 2023-11-30
- Geography
- -
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-19
- Latest update
- 2026-06-19
Value and multiples
100% enterprise value
USD 425M
100% enterprise value | USD
Basis: Public source
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
-
Period not stated
Basis: FundComb estimate
EV / EBITDA
-
EBITDA basis not stated
Basis: FundComb estimate
Amounts paid and other reported values
Original reported amounts and bases; a stake payment is distinct from the estimated whole-company valuation.
Consideration: USD 425M
Google News result title for Business Wire dated 2023-11-30 states Pharmavite announced a $425 million acquisition of Bonafide Health; WWD and other headline results also state $425 million.
Basis
- Reported consideration: USD 425m.
Source summary
Pharmavite Announces $425 Million Acquisition of Bonafide Health to Become Leader in Women’s Health - Business Wire
ConfirmedContinue your research
Related transaction comps
Uqora acquired by Pharmavite
2021-07-08 · Confirmed
View transaction → CPGAu Vodka acquired by Sazerac
2026-08-17 · Confirmed
View transaction → CPGPurely Elizabeth acquired by Ferrero Group
2026-08-14 · Confirmed
View transaction → CPGThe European Candy Group B.V. acquired by Orkla Snacks (Orkla ASA)
2026-07-31 · Confirmed
View transaction →